US Stock MarketDetailed Quotes

SLS Sellas Life Sciences

Watchlist
  • 1.130
  • -0.040-3.42%
Close Nov 29 13:00 ET
  • 1.150
  • +0.020+1.77%
Post 16:48 ET
79.53MMarket Cap-1686P/E (TTM)

Sellas Life Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-13.26%-7.81M
-27.97%-9.68M
11.26%-10.76M
-31.92%-31.41M
6.35%-4.83M
-19.94%-6.89M
-31.33%-7.57M
-69.61%-12.13M
8.50%-23.81M
-3.54%-5.15M
Net income from continuing operations
23.30%-7.11M
15.50%-7.47M
13.80%-9.57M
9.59%-37.34M
10.80%-8.14M
-31.97%-9.27M
-5.06%-8.84M
33.73%-11.1M
-99.53%-41.3M
-38.24%-9.12M
Operating gains losses
----
----
----
88.89%-4K
--0
--0
95.83%-2K
-118.18%-2K
-140.00%-36K
106.82%3K
Other non cash items
12.30%137K
-12.66%138K
58.62%138K
-95.13%495K
372.34%128K
-37.76%122K
578.79%158K
-99.13%87K
344.02%10.16M
98.97%-47K
Change In working capital
-171.11%-1.22M
-544.37%-2.68M
-9.31%-1.81M
-40.70%3.35M
-24.70%2.69M
172.73%1.71M
-73.56%604K
-97.73%-1.66M
174.08%5.64M
636.98%3.57M
-Change in prepaid assets
-30.51%378K
-119.20%-67K
-65.60%-2.44M
-90.98%113K
-7.22%694K
11.93%544K
-44.16%349K
-143.23%-1.47M
206.73%1.25M
-25.72%748K
-Change in payables and accrued expense
-212.82%-1.46M
-692.84%-2.48M
968.18%764K
-22.82%3.75M
-27.90%2.12M
267.90%1.3M
-43.61%419K
-110.76%-88K
372.06%4.86M
966.47%2.95M
-Change in other current liabilities
-3.10%-133K
18.90%-133K
-41.94%-132K
-9.98%-518K
-3.94%-132K
38.86%-129K
-95.24%-164K
-89.80%-93K
-157.38%-471K
30.60%-127K
Cash from discontinued investing activities
Operating cash flow
-13.26%-7.81M
-27.97%-9.68M
11.26%-10.76M
-31.92%-31.41M
6.35%-4.83M
-19.94%-6.89M
-31.33%-7.57M
-69.61%-12.13M
8.50%-23.81M
-3.54%-5.15M
Investing cash flow
Cash flow from continuing investing activities
0
-22.22%-5.5M
0
-3M
-4.5M
0
Net intangibles purchase and sale
--0
----
----
-22.22%-5.5M
--0
---3M
----
----
---4.5M
--0
Cash from discontinued investing activities
Investing cash flow
--0
----
----
-22.22%-5.5M
--0
---3M
----
----
---4.5M
--0
Financing cash flow
Cash flow from continuing financing activities
36,362.96%19.69M
1,527.59%414K
40.95%26.65M
-7.33%22.32M
264.48%3.39M
-49.53%54K
-100.13%-29K
40,121.28%18.9M
99.43%24.08M
1,758.00%929K
Net common stock issuance
--19.49M
303.45%59K
40.82%26.55M
-7.37%22.23M
266.31%3.4M
--0
-100.13%-29K
--18.85M
166.45%23.99M
--929K
Proceeds from stock option exercised by employees
274.07%202K
--355K
88.68%100K
42.35%121K
--14K
42.11%54K
--0
12.77%53K
-97.23%85K
--0
Net other financing activities
----
----
----
---31K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
36,362.96%19.69M
1,527.59%414K
40.95%26.65M
-7.33%22.32M
264.48%3.39M
-49.53%54K
-100.13%-29K
40,121.28%18.9M
99.43%24.08M
1,758.00%929K
Net cash flow
Beginning cash position
-33.51%9.25M
-22.86%18.52M
-84.73%2.63M
-19.72%17.23M
-81.03%4.07M
-48.66%13.91M
67.24%24M
-19.72%17.23M
-39.40%21.46M
-18.70%21.45M
Current changes in cash
220.80%11.88M
8.19%-9.27M
134.40%15.89M
-245.04%-14.6M
65.92%-1.44M
-74.46%-9.84M
-179.27%-10.1M
195.41%6.78M
69.67%-4.23M
14.27%-4.22M
End cash Position
419.32%21.13M
-33.51%9.25M
-22.86%18.52M
-84.73%2.63M
-84.73%2.63M
-81.03%4.07M
-48.66%13.91M
67.24%24M
-19.72%17.23M
-19.72%17.23M
Free cash flow
21.09%-7.81M
3.81%-9.68M
11.26%-10.76M
-30.38%-36.91M
6.35%-4.83M
-72.15%-9.89M
1.90%-10.07M
-69.61%-12.13M
-8.79%-28.31M
-3.54%-5.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -13.26%-7.81M-27.97%-9.68M11.26%-10.76M-31.92%-31.41M6.35%-4.83M-19.94%-6.89M-31.33%-7.57M-69.61%-12.13M8.50%-23.81M-3.54%-5.15M
Net income from continuing operations 23.30%-7.11M15.50%-7.47M13.80%-9.57M9.59%-37.34M10.80%-8.14M-31.97%-9.27M-5.06%-8.84M33.73%-11.1M-99.53%-41.3M-38.24%-9.12M
Operating gains losses ------------88.89%-4K--0--095.83%-2K-118.18%-2K-140.00%-36K106.82%3K
Other non cash items 12.30%137K-12.66%138K58.62%138K-95.13%495K372.34%128K-37.76%122K578.79%158K-99.13%87K344.02%10.16M98.97%-47K
Change In working capital -171.11%-1.22M-544.37%-2.68M-9.31%-1.81M-40.70%3.35M-24.70%2.69M172.73%1.71M-73.56%604K-97.73%-1.66M174.08%5.64M636.98%3.57M
-Change in prepaid assets -30.51%378K-119.20%-67K-65.60%-2.44M-90.98%113K-7.22%694K11.93%544K-44.16%349K-143.23%-1.47M206.73%1.25M-25.72%748K
-Change in payables and accrued expense -212.82%-1.46M-692.84%-2.48M968.18%764K-22.82%3.75M-27.90%2.12M267.90%1.3M-43.61%419K-110.76%-88K372.06%4.86M966.47%2.95M
-Change in other current liabilities -3.10%-133K18.90%-133K-41.94%-132K-9.98%-518K-3.94%-132K38.86%-129K-95.24%-164K-89.80%-93K-157.38%-471K30.60%-127K
Cash from discontinued investing activities
Operating cash flow -13.26%-7.81M-27.97%-9.68M11.26%-10.76M-31.92%-31.41M6.35%-4.83M-19.94%-6.89M-31.33%-7.57M-69.61%-12.13M8.50%-23.81M-3.54%-5.15M
Investing cash flow
Cash flow from continuing investing activities 0-22.22%-5.5M0-3M-4.5M0
Net intangibles purchase and sale --0---------22.22%-5.5M--0---3M-----------4.5M--0
Cash from discontinued investing activities
Investing cash flow --0---------22.22%-5.5M--0---3M-----------4.5M--0
Financing cash flow
Cash flow from continuing financing activities 36,362.96%19.69M1,527.59%414K40.95%26.65M-7.33%22.32M264.48%3.39M-49.53%54K-100.13%-29K40,121.28%18.9M99.43%24.08M1,758.00%929K
Net common stock issuance --19.49M303.45%59K40.82%26.55M-7.37%22.23M266.31%3.4M--0-100.13%-29K--18.85M166.45%23.99M--929K
Proceeds from stock option exercised by employees 274.07%202K--355K88.68%100K42.35%121K--14K42.11%54K--012.77%53K-97.23%85K--0
Net other financing activities ---------------31K------------------------
Cash from discontinued financing activities
Financing cash flow 36,362.96%19.69M1,527.59%414K40.95%26.65M-7.33%22.32M264.48%3.39M-49.53%54K-100.13%-29K40,121.28%18.9M99.43%24.08M1,758.00%929K
Net cash flow
Beginning cash position -33.51%9.25M-22.86%18.52M-84.73%2.63M-19.72%17.23M-81.03%4.07M-48.66%13.91M67.24%24M-19.72%17.23M-39.40%21.46M-18.70%21.45M
Current changes in cash 220.80%11.88M8.19%-9.27M134.40%15.89M-245.04%-14.6M65.92%-1.44M-74.46%-9.84M-179.27%-10.1M195.41%6.78M69.67%-4.23M14.27%-4.22M
End cash Position 419.32%21.13M-33.51%9.25M-22.86%18.52M-84.73%2.63M-84.73%2.63M-81.03%4.07M-48.66%13.91M67.24%24M-19.72%17.23M-19.72%17.23M
Free cash flow 21.09%-7.81M3.81%-9.68M11.26%-10.76M-30.38%-36.91M6.35%-4.83M-72.15%-9.89M1.90%-10.07M-69.61%-12.13M-8.79%-28.31M-3.54%-5.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data